Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma - Wikidata - awgldk - TriplyDB

Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma

Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma

http://www.wikidata.org/entity/Q33869598

about

Role of SOX family of transcription factors in central nervous system tumors Targeting glioma stem cells: a novel framework for brain tumors Selective calcium sensitivity in immature glioma cancer stem cells Dedifferentiation of foetal CNS stem cells to mesendoderm-like cells through an EMT process Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective.The Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma.Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.Suppression of glioma progression by Egln3 Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.Deregulated proliferation and differentiation in brain tumors.Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis.Prevention against diffuse spinal cord astrocytoma: can the Notch pathway be a novel treatment target?Distance in cancer gene expression from stem cells predicts patient survival.Cancer Stem Cells in Glioblastoma Multiforme.MEF promotes stemness in the pathogenesis of gliomas.Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.NCoR controls glioblastoma tumor cell characteristics.TLX-Its Emerging Role for Neurogenesis in Health and Disease.High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.PDGF and PDGF receptors in glioma.Neuronal stem cells in the central nervous system and in human diseases.Maintaining differentiated cellular identity.Epigenetic memory in the context of nuclear reprogramming and cancer.The role of octamer binding transcription factors in glioblastoma multiforme.Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.Mechanisms of tumor cell resistance to the current targeted-therapy agents.Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma.Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme.Sox21 inhibits glioma progression in vivo by forming complexes with Sox2 and stimulating aberrant differentiation.Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.A mesenchymal glioma stem cell profile is related to clinical outcome.G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.Knockdown of SALL4 expression using RNA interference induces cell cycle arrest, enhances early apoptosis, inhibits invasion and increases chemosensitivity to temozolomide in U251 glioma cells.Methylated cis-regulatory elements mediate KLF4-dependent gene transactivation and cell migration Endogenous GABAA receptor activity suppresses glioma growth.

P2860

Q26860974-0005A263-64DF-42B7-9C44-9D3A345F77B6 Q27026818-728A962B-0557-4A7D-808C-7C8972AD2EA9 Q28542816-7260F894-2E0F-42FA-B705-C508670A4867 Q28732522-D0A2B252-FCCA-40A8-90E7-3A77DF2C15A5 Q30252747-88815956-19D2-4205-82AD-434508DDBD01 Q30276803-78C1D058-1F48-4E56-8264-0BEE18A8018F Q33652886-3BFD14C3-B3AB-432E-84AA-EEA66952939C Q33891224-03259F73-194C-4C1F-A343-D86A97C43600 Q33993779-2606C508-DBA4-453D-B26C-1024BB9CA2B8 Q34384193-3DBB68A5-435D-4C2B-B3A8-4CD2BC374B54 Q34684614-C0C27C3B-C2C4-4015-B37B-B7B4B13925E0 Q34859989-B3151311-F26D-4A63-A8AA-007FF9F09F3B Q34947381-7D37BBEA-A331-463D-9F08-7A3B2D914492 Q35356912-7AE8ECCF-8FD2-4462-B34D-BDF5AFB11AEC Q36319754-FE45ED78-FA67-4FC0-8093-74EAC42819CB Q37210629-BD58F015-100F-4FE1-9890-5B3E3C562867 Q37267797-9C6F9402-60C9-4261-92E8-CBDD1C386601 Q37490603-945404CA-DDB1-4D99-8A64-5F4FDACA5E70 Q37492181-961AB9F1-757E-40A3-8D1F-6BFFFF97D038 Q37569901-0D398B72-3DD6-427D-912F-9145E183A8E6 Q37745955-639CA04B-0730-4A8F-9942-B66F0F2CD9CE Q38003175-AF3B1BF1-9D8C-4F94-984F-A94BF6206D9E Q38005043-E0437903-B819-42D5-80B9-05BF888D5A9A Q38011006-8AAEA3A0-BC56-42B6-801B-BE3E3B1DB160 Q38098977-4A45304E-3286-490F-AF04-5BE7E60AEAEC Q38770247-15B14A98-B66D-44C0-AB3E-196B1647BCF8 Q38790973-B9EB0817-96C5-4B19-B42D-03E6BD1C177D Q38828353-45270D9E-D7EE-42CC-B854-5E9A1B7AD496 Q38912979-0633D102-140F-4623-A966-D6B375C38E20 Q38943613-F67CB406-C7F2-43E2-AA06-A5E2117E985B Q39037273-A8854664-B1CA-4D00-AA91-381E1DBF9AE6 Q39184953-D124EFEB-CA2B-42C5-9725-C64A44D2BFA4 Q39424061-77308198-1E08-4FC5-A77D-1CF498809519 Q39561683-409A3051-A4AE-4525-A6EC-5DFCFF299BF2 Q40058197-A200166D-8D79-4DC7-BB3B-E7F4AE7175D6 Q41009856-EAC579E9-D37C-4F42-9DEA-5A7E634DB47B Q41112486-6B7FB212-E6EA-4890-AA00-102E1363EFE0 Q41387631-54DD6C6B-B167-4D9A-B594-2B0976235824 Q42209913-F648FFDB-27F8-47BE-8F11-CB51D8E1751E Q48641867-7B307F5B-7F1E-46FB-888C-C71CE5621E9B

P2860

Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma

http://www.wikidata.org/entity/Q33869598

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Activation of neural and pluri ...... sed malignancy in human glioma

@ast

Activation of neural and pluri ...... sed malignancy in human glioma

@en

type

label

Activation of neural and pluri ...... sed malignancy in human glioma

@ast

Activation of neural and pluri ...... sed malignancy in human glioma

@en

prefLabel

Activation of neural and pluri ...... sed malignancy in human glioma

@ast

Activation of neural and pluri ...... sed malignancy in human glioma

@en

P1433

Q33869598-E904FCD1-5C87-44C7-995F-A3097E0D475F

P1476

Q33869598-425DE1B4-07A7-4E40-8F66-8424ADC8F92F

P2093

Q33869598-007128BD-35AB-4CD4-AA46-A33858DAA050

Q33869598-046E54BA-507B-41F9-8205-30E87E817588

Q33869598-165C72FE-F067-40DF-8625-8FFA402F38AC

Q33869598-3C1F0393-BF8F-4FB5-8958-F66EEC64BFF9

Q33869598-82DD798E-ED13-4AA6-AA35-E48B2341158C

Q33869598-9935BC04-6FBD-4989-8398-CD13F2E6318A

Q33869598-BF3BB73A-D1ED-4B97-A5F8-EFD54992383F

Q33869598-E52E1366-1BA8-41DB-934E-F74924694DB5

Q33869598-FFD366AC-2313-4B53-B6FD-90D3F652EADB

P2860

Q33869598-017694EA-D21E-478F-90D9-55CCF5DA83BA

Q33869598-0FC49E5F-CB48-45E7-B9F1-C1240F96C867

Q33869598-1C0971B6-6B16-4026-BD8A-CF6AE9BC9612

Q33869598-2B089578-E343-4796-B662-8F51646D3672

Q33869598-2D40ED6D-64FC-44CC-BD37-B29E3AF2CB41

Q33869598-2E4377E4-84B2-47F7-BC9E-4293BA5B3885

Q33869598-3A96D62F-068D-495A-B126-57029BE1208B

Q33869598-3CC3212B-C190-4E65-B673-786A6709BCB4

Q33869598-445D31CD-EEA2-41E6-805B-1B7A8570EBE6

Q33869598-4DB51CEC-DFC1-4EEB-B5F0-2BA174D1B91D

P304

Q33869598-03B3C911-09A5-4441-869E-60BA0205CC90

P31

Q33869598-8C763ABD-98D2-46D5-AC89-D19819192437

P356

Q33869598-6A8FFBE7-D612-4838-8D64-6E69C2FCC724

P407

Q33869598-CB23C625-0B86-40A0-99DB-9685133D0E7F

P433

Q33869598-B67AA68C-786E-441A-821E-46C7905DC32F

P478

Q33869598-0EE2CCB1-21DC-492D-9E3C-774E07E928D5

P50

Q33869598-09F0BAEB-77B8-443A-9405-46DA8748D708

Q33869598-A9A8379A-3314-4EFF-924B-11D2FF70A22B

Q33869598-F6BCE19A-B4DB-4973-86AE-237206D07E2C

P577

Q33869598-939153DD-7EF4-4559-AD62-E93B896DC3E2

P5875

Q33869598-D83490E9-2882-4714-A5B0-2E945F542950

P698

Q33869598-D4B93B92-FA50-430A-A3F4-02C7AE0BE703

P932

Q33869598-6CFFC553-059D-449F-AAE6-08DF854EF56F

P356

JOURNAL.PONE.0018454

P1433

P1476

Activation of neural and pluri ...... sed malignancy in human glioma

@en

P2093

Abiel Orrego

http://www.w3.org/2001/XMLSchema#string

Göran Hesselager

http://www.w3.org/2001/XMLSchema#string

Johan Holmberg

http://www.w3.org/2001/XMLSchema#string

Jonas Muhr

http://www.w3.org/2001/XMLSchema#string

Monica Nistér

http://www.w3.org/2001/XMLSchema#string

Outi Hovatta

http://www.w3.org/2001/XMLSchema#string

Sueli Mieko Oba-Shinjo

http://www.w3.org/2001/XMLSchema#string

Suely Kazue Nagahashi Marie

http://www.w3.org/2001/XMLSchema#string

Xiaobing He

http://www.w3.org/2001/XMLSchema#string

P2860

Core transcriptional regulatory circuitry in human embryonic stem cells

The 2007 WHO classification of tumours of the central nervous system

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Efficient selection for high-expression transfectants with a novel eukaryotic vector

Identification of human brain tumour initiating cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Identification of a cancer stem cell in human brain tumors

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Vertebrate neurogenesis is counteracted by Sox1-3 activity

P304

e18454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0018454

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Christer Ericsson

P577

2011-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51042552

http://www.w3.org/2001/XMLSchema#string

P698

21483788

http://www.w3.org/2001/XMLSchema#string

P932

3069091

http://www.w3.org/2001/XMLSchema#string